Recent Updates
Recently added Catalysts
VNDA Positive Sentiment

Vanda Pharmaceuticals to Announce First Quarter 2023 Financial Results on May 3, 2023

Thursday, April 27, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Vanda Pharmaceuticals Inc. has announced that it will release its financial results for the first quarter of 2023 on May 3, 2023, after the market closes. A conference call will follow at 4:30 PM ET to discuss the results and corporate activities. Investors are invited to participate and can access the conference call via a dedicated number. A replay of the call will be available for a limited time after the event.
Price reaction · baseline $6.29 (2023-04-26 close) · hit after-hours · 1 other VNDA headline(s) in the window, move may be shared
day 0 close · peak
-1.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Vanda Pharmaceuticals is set to announce its Q1 2023 financial results, indicating ongoing operational activities.
  • The company will provide an opportunity for stakeholders to engage during the conference call.
  • The results announcement suggests Vanda is in a position to communicate financial health and corporate developments.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis

Full Press Release Details

Conference Call and Webcast to Follow
WASHINGTON, April 27, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2023 on Wednesday, May 3, 2023, after the market closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, May 3, 2023, during which management will discuss the first quarter 2023 financial results and other corporate activities. To participate in the conference call, please dial 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and use passcode 7072297.
The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, May 3, 2023, beginning at 8:30 PM ET and will be accessible until Wednesday, May 10, 2023, at 8:30 PM ET. The replay call-in number is 1-800-770-2030 for domestic callers and 1-609-800-9909 for international callers. The passcode number is 7072297.
About Vanda Pharmaceuticals Inc.
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.

Frequently Asked Questions

When will Vanda Pharmaceuticals release Q1 2023 results?

Vanda Pharmaceuticals will release Q1 2023 results on May 3, 2023, after market close.

What time is the Vanda conference call on May 3, 2023?

The conference call is scheduled for 4:30 PM ET on May 3, 2023.

How can I participate in the conference call?

Dial 1-800-715-9871 for domestic or 1-646-307-1963 for international access.

Is the conference call available for replay?

Yes, a replay will be available from 8:30 PM ET on May 3 to May 10, 2023.

Where can I find the conference call details online?

Details will be available on Vanda’s website, www.vandapharma.com.

ShareAdd on Google
Tags: VNDA Viatris Investor Conferences Healthcare Vanda Pharmaceuticals Q1 2023 results financial results conference call
Last updated: Apr 27, 2023

Biotech snapshot

Cash runway
$170M liquidity · $10M/mo burn
~16 mo
Low dilution risk
Lead asset
ImsidolimabPhase 2
Palmoplantar Pustulosis →

Catalyst track record

+121%
best trade around VNDA's most recent catalyst

Peak hindsight return over a 120-day window, across 7 tracked FDA/PDUFA catalysts for VNDA.

See every catalyst's timing & PoA →